Status: Recruiting
A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
This study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-2005 for Intravesical perfusion in patients with intermediate and high-risk non-muscle invasive bladder cancer.
Participants needed: 170
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.Updated: Dec 3, 2024Locations: 1
Eligibility criteria
Subjects must voluntarily agree to participate in the trial and sign a written i... [+5]
Received TURBT or other surgical treatment or radiotherapy for bladder lesions w... [+6]